1-76628690-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152996.4(ST6GALNAC3):c.802C>A(p.Leu268Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000453 in 1,611,976 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152996.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ST6GALNAC3 | NM_152996.4 | c.802C>A | p.Leu268Ile | missense_variant | 5/5 | ENST00000328299.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ST6GALNAC3 | ENST00000328299.4 | c.802C>A | p.Leu268Ile | missense_variant | 5/5 | 1 | NM_152996.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 151844Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000200 AC: 50AN: 249992Hom.: 0 AF XY: 0.000229 AC XY: 31AN XY: 135162
GnomAD4 exome AF: 0.000465 AC: 679AN: 1460132Hom.: 0 Cov.: 31 AF XY: 0.000468 AC XY: 340AN XY: 726414
GnomAD4 genome AF: 0.000342 AC: 52AN: 151844Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74166
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.802C>A (p.L268I) alteration is located in exon 5 (coding exon 5) of the ST6GALNAC3 gene. This alteration results from a C to A substitution at nucleotide position 802, causing the leucine (L) at amino acid position 268 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at